Vascular Patches Market Will Generate Booming Growth Opportunities to 2031

The global vascular patches market is predicted to grow by 5.8% between 2021 and 2031, with a market value of around US$ 144.8 million in 2022. By 2031, the Vascular Patches market is anticipated to be worth US$ 241.4 million. Biologic vascular patches by materials represented a 52.9% share of the global market in 2020, according to Future Market Insights (FMI).

The global prevalence of cardiovascular illnesses is increasing. The increased prevalence of heart illnesses will drive the market for vascular patches. Vascular patches have developed as a new revenue stream for biotech and pharmaceutical firms. Increasing technological breakthroughs in the cardiac therapeutic field have aided the widespread use of vascular patches for revascularization as an efficient technique of therapeutic use of vascular patches.

The increased availability of high-quality patch products worldwide is addressing unmet requirements for cardiological therapy. Physical inactivity, nicotine usage and smoking, as well as a poor diet, are major contributors to the rising burden of cardiovascular disease.

The advent of cardiac management has expanded the diagnostic approach to increasing life expectancy as well as management, moving the vascular patches industry forward.

Key market participants are concentrating on the development of unique goods employing current biologic resources for innovative product identification, as well as the provision of proprietary remedies. Furthermore, the prevalence of unfavourable situations such as organ failure and stroke in cardiac patients during the surgical management procedure has prompted the use of vascular patches in major healthcare facilities throughout the world.

Key Players

  • Braile Biomedica
  • Baxter International
  • Getinge Ab (Maquet)
  • B. Braun Melsungen AG
  • W. L. Gore & Associates
  • Admedus
  • Cryolife
  • Edwards Lifesciences
  • Others

Browse More@ https://www.futuremarketinsights.com/reports/vascular-patches-market

Key Market Segments Covered in Vascular Patches Industry Research

By Material:

  • Synthetic vascular patches
  • Biologic vascular patches

By Application:

  • Carotid Endarterectomy
  • Open Repair of Abdominal Aneurysm
  • Vascular bypass Surgery
  • Peripheral vascular reconstruction
  • Others

By End User:

  • Hospitals
  • Trauma Care Centers
  • Academic & Research Institutes

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more